Quick Answer
AtriCure, Inc. reported Diluted EPS of $0.24 per share (loss) for fiscal year 2025.
AtriCure, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$0.24 | +74.7% |
| 2024 | -$0.95 | -43.9% |
| 2023 | -$0.66 | +35.3% |
| 2022 | -$1.02 | -193.6% |
| 2021 | $1.09 | +195.6% |
| 2020 | -$1.14 | -21.3% |
| 2019 | -$0.94 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$0.01 | +94.1% | +92.3% |
| June 30, 2025 | -$0.13 | +23.5% | +7.1% |
| March 31, 2025 | -$0.14 | +50.0% | +17.6% |
| September 30, 2024 | -$0.17 | +15.0% | +0.0% |
| June 30, 2024 | -$0.17 | -54.5% | +39.3% |
| March 31, 2024 | -$0.28 | -100.0% | -40.0% |
| September 30, 2023 | -$0.20 | +25.9% | -81.8% |
| June 30, 2023 | -$0.11 | +65.6% | +21.4% |
- AtriCure, Inc. showed an increase of +74.7% in Diluted EPS compared to the prior fiscal year.
- Over the 2019–2025 period, AtriCure, Inc.’s diluted eps has grown by 74.5% (from $0.94 per share (loss) to $0.24 per share (loss)).
- The most recent figure is from AtriCure, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 19, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: